Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

  • Showing results for a modified search because your search retrieved no results.
1.

Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.

Große K, Schmidt RE, Witte T, Baerlecken NT.

Scand J Rheumatol. 2013;42(3):215-9. doi: 10.3109/03009742.2012.733959.

PMID:
23682607
2.

Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.

Baerlecken NT, Linnemann A, Gross WL, Moosig F, Vazquez-Rodriguez TR, Gonzalez-Gay MA, Martin J, Kötter I, Henes JC, Melchers I, Vaith P, Schmidt RE, Witte T.

Ann Rheum Dis. 2012 Jun;71(6):943-7. doi: 10.1136/annrheumdis-2011-200413. Epub 2012 Jan 5.

PMID:
22228484
3.

Association of ferritin antibodies with Takayasu arteritis.

Große K, Witte T, Moosig F, Hoyer BF, Lansche C, Schmidt RE, Baerlecken NT.

Clin Rheumatol. 2014;33(10):1523-6. doi: 10.1007/s10067-014-2764-2. Epub 2014 Sep 2.

PMID:
25178778
4.

Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica.

Schmits R, Kubuschok B, Schuster S, Preuss KD, Pfreundschuh M.

Clin Exp Immunol. 2002 Feb;127(2):379-85.

5.

Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.

Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.

Semin Arthritis Rheum. 2001 Feb;30(4):257-71. Review.

PMID:
11182026
6.

A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.

Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG.

J Rheumatol. 1995 Sep;22(9):1694-7. Erratum in: J Rheumatol 1996 Mar;23(3):575.

PMID:
8523347
7.

Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM.

Ann Rheum Dis. 2004 Jan;63(1):54-60.

8.

Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.

Berthelot JM, Lamour A, Mottier D, Pennec YL, Dueymes M, Jouquan J, Le Goff P, Youinou P.

Ann Med Interne (Paris). 1992;143(7):429-32.

PMID:
1300861
9.

Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.

Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W.

J Rheumatol. 1998 Nov;25(11):2140-5.

PMID:
9818656
10.

Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.

Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.

Rheumatology (Oxford). 2003 Sep;42(9):1055-61. Epub 2003 Apr 16.

PMID:
12730520
11.

[Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].

Rovenský J, Tuchynová A, Poprac P, Blazíková S, Bosák V, Stvrtinová V.

Vnitr Lek. 2006 Jul-Aug;52(7-8):691-6. Slovak.

PMID:
16967610
12.

Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.

van der Geest KS, Abdulahad WH, Rutgers A, Horst G, Bijzet J, Arends S, Roffel MP, Boots AM, Brouwer E.

Rheumatology (Oxford). 2015 Aug;54(8):1397-402. doi: 10.1093/rheumatology/keu526. Epub 2015 Feb 26.

PMID:
25724206
13.

HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.

Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ.

Arthritis Rheum. 1994 Apr;37(4):514-20.

PMID:
8147928
14.

Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.

Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, Capozzoli N, Baricchi R, Boiardi L, Chiaravalloti F, et al.

Arthritis Rheum. 1991 Mar;34(3):351-6.

PMID:
2003856
15.

Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.

Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD.

J Rheumatol. 2009 Oct;36(10):2269-76. doi: 10.3899/jrheum.090075. Epub 2009 Aug 14.

PMID:
19684157
16.

Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.

Samson M, Audia S, Fraszczak J, Trad M, Ornetti P, Lakomy D, Ciudad M, Leguy V, Berthier S, Vinit J, Manckoundia P, Maillefert JF, Besancenot JF, Aho-Glele S, Olsson NO, Lorcerie B, Guillevin L, Mouthon L, Saas P, Bateman A, Martin L, Janikashvili N, Larmonier N, Bonnotte B.

Arthritis Rheum. 2012 Nov;64(11):3788-98. doi: 10.1002/art.34647.

17.

Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.

van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM, Bos NA, Boots AM, Brouwer E.

Arthritis Rheumatol. 2014 Jul;66(7):1927-38. doi: 10.1002/art.38625.

18.

Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.

Narváez J, Bernad B, Díaz Torné C, Momplet JV, Montpel JZ, Nolla JM, Valverde-García J.

J Rheumatol. 2006 Jul;33(7):1293-8. Epub 2006 Jun 15.

PMID:
16783861
19.

Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.

Gonzalez-Gay MA.

Semin Arthritis Rheum. 2004 Apr;33(5):289-93. Review.

PMID:
15079759
20.

Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.

Espinoza LR, Jara LJ, Silveira LH, Martínez-Osuna P, Zwolinska JB, Kneer C, Aguilar JL.

Am J Med. 1991 Apr;90(4):474-8.

PMID:
2012088

Supplemental Content

Support Center